# Collegium Pharmaceutical, Inc: Form 8-K, filed Mar 19, 2026

- Company: [Collegium Pharmaceutical, Inc](/companies/coll.md) (CIK 1267565)
- Form: 8-K
- Filed: 2026-03-19
- Accepted by EDGAR: Mar 19, 2026, 17:06 ET
- Period: 2026-03-19
- Accession: 0001104659-26-032166
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1267565/000110465926032166/tm269336d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1267565/000110465926032166/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1267565/000110465926032166/tm269336d1_8k.htm

Filed Mar 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-032166. Last ingested by Listed: Oct 30, 2026, 11:26 ET. No prices; not investment advice.